CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Project description

Personalised medicine for gastric cancer patients

Gastric cancer (GC) is the third leading cause of cancer death worldwide. The survival rate for patients with advanced GC is about 12 months. The EU-funded LEGACy project will improve GC outcomes by implementing actions for an earlier diagnosis and suggesting optimal treatment options according to patient characteristics. LEGACy approaches personalised medicine at the three levels of prevention in the central and eastern Europe, and in Central and South America, analysing the reasons for the diagnosis delay as well as an integral analysis of the epidemiological facts correlated with the multi-omic profile of these patients. Finally, the project will train young researchers and educate the general population on GC risk factors and symptoms.

Fields of science

• medical and health sciences › health sciences › public and environmental health
• social sciences › sociology › demography › mortality
• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.3.1.3. - Treating and managing disease

Topic(s)

• SC1-BHC-18-2018 - Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)

Call for proposal

H2020-SC1-2018-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA

Address

Av Menendez Pelayo 4
46010 Valencia
Spain

Activity type

Research Organisations

EU contribution

€ 638 315

Participants (10)

Instituto Nacional de Cancerología

Mexico

EU contribution

€ 0

Address

Av. San Fernando 22
01480 Mexico

Activity type

Research Organisations

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile

EU contribution

€ 305 235

Address

Avenida Libertador Bernardo O'higgins 340
8331150 Santiago

Activity type

Higher or Secondary Education Establishments

FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)

Spain

EU contribution

€ 550 000

Address

Calle Nazaret 115-117
08035 Barcelona

Activity type

Research Organisations

UNIVERSITAET LEIPZIG

Germany

EU contribution

€ 131 156,25

Address

Ritterstrasse 26
04109 Leipzig

Activity type

Higher or Secondary Education Establishments

EUROPEAN CANCER PATIENT COALITION

Belgium

EU contribution

€ 197 750

Address

Rue Montoyer 40
1000 Bruxelles

Activity type

Other

IPATIMUP - INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO PCUP

Portugal

EU contribution

€ 660 162,50

Address

Rua Julio Amaral De Carvalho 45
4200 135 Porto

Activity type

Research Organisations

CABALLERO LLANO CARMELO CESAR

Paraguay

EU contribution

€ 216 093,75

Address

Fortin Toledo 524 Apt 2
Asuncion

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

ALEXANDER FLEMING SA

Argentina

EU contribution

€ 131 625

Address

Carmer 1180
C1426NZ Buenos Aires

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

ANAXOMICS BIOTECH SL

Spain

EU contribution

€ 275 218,75

Address

Calle Diputacio 237, P 1 Pta 1
08007 Barcelona

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

STICHTING VUMC

Netherlands

EU contribution

€ 471 875

Address

De Boelelaan 1117
1081 HV Amsterdam

Activity type

Research Organisations